HK Stock Market Move | GIANT BIOGENE (02367) drops over 4%, removed from MSCI China Index, October growth turns significantly negative.

GIANT BIOGENE (02367) fell over 4%, down 4.51% as of press time to HK$20.34, with turnover of HK$52.3634 million. On the news front, on November 12, MSCI announced the results of its November 2026 quarterly index review, which will take effect after the close on November 30. Among the changes, 38 stocks including GIANT BIOGENE were removed from the MSCI China Index. Separately, according to CMBI's observations on beauty e-commerce, among key domestic companies, GIANT BIOGENE's growth turned significantly negative, falling 7.0% year-on-year in October versus growth of 14.0% in September, mainly dragged down by Comfy and the Taotian channel. In addition, in this year's Tmall beauty TOP20 list, Comfy, which was on the list last year, dropped out of the top 20 this year.